Renaissance Technologies LLC 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-11 10:24 am Purchase | 2020-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | Renaissance Technologies LLC | 204,264 8.520% | 172,121 (+535.47%) | Filing |
| 2020-02-12 12:28 pm Purchase | 2019-01-11 | 13G | Acorda Therapeutics, Inc. ACOR | Renaissance Technologies LLC | 32,144 8.030% | 32,144 (New Position) | Filing |